Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

RNA
Avidity Biosciences, Inc. Common Stock
stock NASDAQ

At Close
Feb 27, 2026 3:59:46 PM EST
14.83USD-79.629%(-57.97)7,919,658
14.75Bid   14.77Ask   0.02Spread
Pre-market
Feb 27, 2026 9:28:30 AM EST
14.55USD-80.014%(-58.25)1,173,430
After-hours
Feb 27, 2026 4:53:30 PM EST
14.00USD-5.597%(-0.83)33,712
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 10, 2021
07:51AM EST  10 Biggest Price Target Changes For Friday   Benzinga
04:35AM EST  SVB Leerink Maintains Outperform on Avidity Biosciences, Raises Price Target to $53   Benzinga
Dec 9, 2021
09:00AM EST  Avidity Biosciences Highlights FSHD Program at Virtual Investor and Analyst   PR Newswire
Nov 9, 2021
05:51PM EST  Avidity Biosciences Q3 EPS $(0.68) Down From $(0.31) YoY, Sales $2.16M Up From $1.75M YoY   Benzinga
04:05PM EST  Avidity Biosciences Reports Third Quarter 2021 Financial Results and Recent   PR Newswire
Nov 4, 2021
09:35AM EDT  Avidity Announces First Person Dosed With An Antibody Oligonucleotide Conjugate   Benzinga
Nov 2, 2021
04:05PM EDT  Avidity Biosciences to Participate in Upcoming Investor Conferences   PR Newswire
Oct 18, 2021
09:15AM EDT  Avidity Biosciences Announces FDA Grants Fast Track Designation To AOC 1001 For The Treatment Of Myotonic Dystrophy Type 1   Benzinga
09:06AM EDT  Avidity Biosciences Says FDA Grants Fast Track Designation To AOC 1001 For Treatment Of Myotonic Dystrophy Type 1   RTTNews
09:04AM EDT  FDA Grants Fast Track Designation to AOC 1001 for the Treatment of Myotonic   PR Newswire
Sep 7, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021   Benzinga
07:38AM EDT  Evercore ISI Group Initiates Coverage On Avidity Biosciences with Outperform Rating, Announces Price Target of $50   Benzinga
Aug 31, 2021
09:30AM EDT  Avidity Biosciences to Participate in Upcoming Investor Conferences   PR Newswire
Aug 30, 2021
12:28PM EDT  Avidity Biosciences Sponsored Study Titled 'Phase 1/2 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients' Posted To ClinicalTrials Website   Benzinga
Aug 25, 2021
04:05PM EDT  Avidity Biosciences Announces Changes to its Board of Directors   PR Newswire
Aug 24, 2021
08:36AM EDT  European Medicines Agency Grants Orphan Designation For AOC 1001   Benzinga
08:33AM EDT  Avidity Biosciences : EMA Grants Orphan Designation For AOC 1001   RTTNews
08:30AM EDT  European Medicines Agency (EMA) Grants Orphan Designation for AOC 1001   PR Newswire
Aug 16, 2021
08:37AM EDT  Avidity Collaborates With FSHD Trial Network To Support Development Of Biomarkers For Future Clinical Trial Use   RTTNews
08:35AM EDT  Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use   Benzinga
08:30AM EDT  Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network   PR Newswire
Aug 10, 2021
08:44AM EDT  Credit Suisse Maintains Outperform on Avidity Biosciences, Lowers Price Target to $36   Benzinga
Aug 9, 2021
05:10PM EDT  Avidity Biosciences Q2 EPS $(0.70) Up From $(1.23) YoY, Sales $2.61M Up From $1.54M YoY   Benzinga
04:05PM EDT  Avidity Biosciences Reports Second Quarter 2021 Financial Results and Recent   PR Newswire
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 3, 2021
09:40PM EDT  Avidity Biosciences Prices Public Offering Of 8 Mln Shares At $18.00/shr   RTTNews
09:17PM EDT  Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock   PR Newswire
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Aug 2, 2021
04:13PM EDT  Avidity Biosciences, Inc. Announces Proposed Public Offering Of $100M Of Common Stock   Benzinga
04:01PM EDT  Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock   PR Newswire
12:38PM EDT  Avidity Biosciences Shares Gain As Its Oligonucleotide Candidate Enters Early-Stage Trial In Muscle Wasting Disorder   Benzinga
08:06AM EDT  Avidity Biosciences Receives IND Clearance From FDA To Proceed With Phase 1/2 MARINA Trial Of AOC 1001   RTTNews
08:06AM EDT  Avidity Biosciences Receives IND Clearance From FDA To Proceed With Phase 1/2 MARINA Trial Of AOC 1001 In Adults With Myotonic Dystrophy   Benzinga
08:01AM EDT  Avidity Biosciences Receives IND Clearance from FDA to Proceed with the Phase   PR Newswire
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 2, 2021
04:24PM EDT  Avidity Biosciences Says Entered Into Sales Agreement With Cowen And Company; Says May, From Time To Time, Sell Common Stock Having Offering Price Of Up To $150 Through Cowen   Benzinga
Jun 17, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2021   Benzinga
09:18AM EDT  Needham Initiates Coverage On Avidity Biosciences with Buy Rating, Announces Price Target of $50   Benzinga
May 19, 2021
09:00AM EDT  Avidity Biosciences Announces Updates on the Pipeline and Platform at Virtual   PR Newswire
May 12, 2021
04:36PM EDT  Avidity Biosciences Q1 EPS $(0.64) Up From $(2.14) YoY   Benzinga
04:05PM EDT  Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent   PR Newswire
May 11, 2021
09:39AM EDT  Lilly, MiNA Ink Broad RNA Deal Worth $1.25B   Benzinga
May 3, 2021
08:55AM EDT  Avidity Biosciences to Host Virtual Investor and Analyst Event on May 19, 2021   PR Newswire
Apr 16, 2021
09:03AM EDT  Avidity Biosciences To Present Oral Presentation On AOC 1001 For DM1 At AAN   RTTNews
Apr 14, 2021
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 26, 2021
07:28AM EDT  The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs   Benzinga
Mar 25, 2021
04:05PM EDT  Avidity Biosciences to Participate in Upcoming Investor Conferences   PR Newswire
Mar 15, 2021
04:07PM EDT  Avidity Biosciences Q4 EPS $(0.43)   Benzinga
04:05PM EDT  Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results   PR Newswire
Feb 19, 2021
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
Feb 17, 2021
04:05PM EST  Avidity Biosciences to Present at the 10th Annual SVB Leerink Global Healthcare   PR Newswire
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
08:05AM EST  The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment   Benzinga
Jan 29, 2021
07:45AM EST  The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO   Benzinga
Jan 21, 2021
08:30AM EST  Avidity Biosciences Appoints W. Michael Flanagan, Ph.D. as Chief Technical   PR Newswire
Jan 11, 2021
08:39AM EST  Avidity Biosciences Adds Tamar Thompson Jean Kim To Its Board, Replacing Todd Brady And Michael Marti   RTTNews
08:31AM EST  Avidity Biosciences Announces Changes to its Board of Directors   PR Newswire
Jan 8, 2021
08:37AM EST  Avidity Biosciences Announces 2021 Pipeline Updates   Benzinga
08:37AM EST  Avidity Biosciences Announces Research Collaboration With MyoKardia   Benzinga
08:33AM EST  Avidity Biosciences Says AOC 1001 For DM1 On Track For Initiation Of Phase 1/2 Study In 2H 2021   RTTNews
08:30AM EST  Avidity Biosciences Announces 2021 Pipeline Updates and Research Collaboration   PR Newswire
Dec 22, 2020
04:05PM EST  Avidity Biosciences to Present at the 39th Annual J.P. Morgan Healthcare   PR Newswire
Dec 21, 2020
04:05PM EST  Avidity Biosciences Announces Addition to the Nasdaq Biotechnology Index   PR Newswire
Dec 8, 2020
11:06PM EST  The lockup period of Avidity Biosciences (RNA) ends Wednesday, i.e., on December 9, 2020.   RTTNews
Nov 10, 2020
04:48PM EST  Avidity Biosciences Q3 EPS $(0.31) Up From $(2.43) YoY, Sales $1.75M Up From $650.00K YoY   Benzinga
04:05PM EST  Avidity Biosciences Reports Third Quarter 2020 Financial Results and Recent   PR Newswire
Nov 5, 2020
04:05PM EST  Avidity Biosciences to Present at the Credit Suisse 29th Annual Virtual   PR Newswire
Sep 28, 2020
04:05PM EDT  Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic   PR Newswire
Sep 14, 2020
04:05PM EDT  Avidity Biosciences to Present at Several Upcoming Virtual Scientific Meetings   PR Newswire
Sep 8, 2020
08:32AM EDT  Avidity Biosciences Enters Into Collaboration To Study The Natural History Of Myotonic Dystrophy Type 1   Benzinga
08:14AM EDT  Avidity Biosciences Enters Into Collaboration Supporting END-DM1   RTTNews
08:01AM EDT  Avidity Biosciences Enters into Collaboration to Study the Natural History of   PR Newswire
Sep 3, 2020
04:06PM EDT  Avidity Biosciences to Present at the 2020 Wells Fargo Virtual Healthcare   PR Newswire
Aug 10, 2020
04:06PM EDT  Avidity Biosciences Reports Second Quarter 2020 Financial Results and Recent   PR Newswire
Jul 27, 2020
08:22AM EDT  Avidity Biosciences Appointes Jae Kim, M.D. As Chief Medical Officer   Benzinga
08:01AM EDT  Avidity Biosciences Appoints Jae Kim As Chief Medical Officer   RTTNews
08:01AM EDT  Avidity Biosciences Appoints Jae Kim, M.D. as Chief Medical Officer   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC